Please login to the form below

Not currently logged in
Email:
Password:

AS

This page shows the latest AS news and features for those working in and with pharma, biotech and healthcare.

Q&A: Isabel Gibson

Q&A: Isabel Gibson

There are so many! But I will always have a soft spot for the London Grind chain (Shoreditch Grind/Clerkenwell Grind, etc) as this is where I did so many of

Latest news

  • Pearls of wisdom Pearls of wisdom

    Misinformation may be as dangerous as the virus itself. Countless groups have sprung up promising cures and antidotes to the virus. ... Secondly, this list is not meant to be a retrospective analysis of what we did as a society to combat COVID-19.

  • Novavax starts first phase 3 COVID-19 vaccine trial in the UK Novavax starts first phase 3 COVID-19 vaccine trial in the UK

    The trial will aim to enrol at least 25% of participants over the age of 65, as well as give priority to groups that have been the most affected by

  • FDA sets January decision date for Xalkori in ALK-positive lymphoma FDA sets January decision date for Xalkori in ALK-positive lymphoma

    ALCL is a rare form of non-Hodgkin lymphoma, and is characterised either as ALK-positive or ALK-negative disease.

  • Stop that! Stop that!

    As a chemist, I had absorbed the idea of reductionism, that phenomena could be condensed into a simple ‘x plus y causes z’ explanation. ... As ever, let me make a small diversion into the science before coming back to the practical implication.

  • Keytruda doubles five-year survival rate in NSCLC Keytruda doubles five-year survival rate in NSCLC

    At the five-year time point, the overall survival rate for patients receiving Keytruda was twice as high compared to chemotherapy (31.9% and 16.3% respectively). ... In 2019, the US Food and Drug Administration (FDA) approved an expanded label for

More from news
Approximately 2 fully matching, plus 7,476 partially matching documents found.

Latest Intelligence

  • Surviving cancer: a new era for patients Surviving cancer: a new era for patients

    In this current climate, now more than ever, a shift in perspective is needed – from seeing cancer as an intense battle you either win or lose, to viewing it as a ... Looking at cancer as ‘manageable’ rather than a ‘catastrophe’ allows a

  • How COVID-19 is accelerating the threat of antimicrobial resistance How COVID-19 is accelerating the threat of antimicrobial resistance

    Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19. ... As HCPs have shared, there is a threat that COVID-19 will accelerate AMR, and antimicrobial stewardship needs to be upheld.

  • Could formulary intelligence be your brand differentiator?

    Over the years, pharma companies have used it as a baseline indicator of performance measurement – but its value is so much greater. ... As the industry battles to arrest the decline in R&D ROI and accelerate the commercial value of new innovation, the

  • The flexible salesforce The flexible salesforce

    1. Using January as a benchmark and taking account of all promotional channels, activity volumes fell significantly between March and June. ... with pharma as long as it remains additive and not disruptive to their ability to deliver care.

  • Navigating engagement and remote working during the pandemic Navigating engagement and remote working during the pandemic

    Would moving to a fully remote model ever have been considered as an option for organisations prior to 2020? ... Resources that are available for employees to access – such as counselling lines, facilitating the sharing of hints, tips and experiences,

More from intelligence
Approximately 0 fully matching, plus 1,198 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1,155 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 1,044 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....
Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...

Infographics